Scheme
ICICI Prudential Nifty Healthcare ETF
Holds 20 companies worth ₹231 Cr in Sept 2026.
Fund house
ICICIThe fund house that runs this scheme.AUM
₹231 CrICICI Prudential Nifty Healthcare ETF's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 2.3% on Aug 2026, ₹237 Cr.Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 17.0% of this scheme's NAV.Fund manager
Nishit PatelRuns its co-manager part since 18 May 2021, as the fund house dates it. With Ashwini Bharucha (co-manager), Venus Ahuja (co-manager).
Overview(5 Nov 2025)
Fund managers3
- Nishit PatelCo-manager · May 2021 · 7y · B.Com
- Ashwini BharuchaCo-manager · Dec 2024
- Venus AhujaCo-manager · Nov 2025 · 3y · B.Com
- Ashwini ShindeNov 2024 – Nov 2025
- Priya SridharFeb 2024 – Dec 2024
Key facts
- Benchmark
- Nifty Healthcare TRI
- Risk
- Very High
- Expense
- Actual expenses for the month ended October 31, 2025) 0.15%
- Exit load
- Nil
- Started
- 18 May 2021
- Minimum
- During Ongoing/Continuous Offer: On Stock Exchanges: Investors can buy/sell units of the Scheme in round lot of 1 unit and in multiples thereof. Directly with the Mutual Fund: Investors can buy or sell units of the scheme in creation unit size and its multiples. Further, any application by investors, other than Market Makers, must be for an amount exceeding INR 25 crores. However, the aforementioned threshold of INR 25 crores shall not apply to investors falling under the following categories (until such time as may be specified by SEBI/AMFI): a. Schemes managed by Employee Provident Fund Organisation, India; b. Recognised Provident Funds, approved Gratuity funds and approved superannuation funds under Income Tax Act, 1961. All direct transactions in units of the Scheme by eligible investors with the AMC/the Fund shall be at intra-day NAV based on the actual execution price of the underlying portfolio..
Source.Its Scheme Summary Document as of 5 Nov 2025 at AMFI.
What changed(6 changes)
Nov 2025
4 changes
- 5 Novas co-manager
- 5 Novas co-manager
- 5 Novran it as co-manager from Nov 2024
- Expense ratio5 NovActual expenses for the month ended November 30, 2024: 0.15% → Actual expenses for the month ended October 31, 2025) 0.15%
Dec 2024
2 changes
- 20 Decran it as co-manager from Feb 2024
- Expense ratio20 DecRegular 0.15% → Actual expenses for the month ended November 30, 2024: 0.15%
Source.Its filings at NSE, since Nov 2024.
Fund managers over time(May 2021 – now)
MainCoSlice2022202320242025
Costs(Nov 2024 – Nov 2025)
Direct plan, 7 Nov 2024
–%
Regular plan 0.15% · Exit load nil
Objective and risk(5 Nov 2025)
Objective
The investment objective of the scheme is to provide returns before expenses that closely correspond to the total return of the underlying index subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Risk, type and benchmark
- Riskometer
- Very High
- At launch
- Very High
- Type
- Open Ended
- Benchmark
- Nifty Healthcare TRI
Asset allocation it may hold% of NAV
- Equity and Equity related securities of companies constituting the underlying index (Nifty Healthcare Index)Allowed95–100%Holds100.0%
- Money Market Instruments including TREPs*, Units of debt schemesAllowed0–5%
- Units of Debt ETFsAllowed0–5%
Holds in Sept 2026.100.0% equity
How to invest(5 Nov 2025)
Buying
- To start
- During Ongoing/Continuous Offer: On Stock Exchanges: Investors can buy/sell units of the Scheme in round lot of 1 unit and in multiples thereof. Directly with the Mutual Fund: Investors can buy or sell units of the scheme in creation unit size and its multiples. Further, any application by investors, other than Market Makers, must be for an amount exceeding INR 25 crores. However, the aforementioned threshold of INR 25 crores shall not apply to investors falling under the following categories (until such time as may be specified by SEBI/AMFI): a. Schemes managed by Employee Provident Fund Organisation, India; b. Recognised Provident Funds, approved Gratuity funds and approved superannuation funds under Income Tax Act, 1961. All direct transactions in units of the Scheme by eligible investors with the AMC/the Fund shall be at intra-day NAV based on the actual execution price of the underlying portfolio..
Selling and switching
- To redeem
- During Ongoing/Continuous Offer: On Stock Exchanges: Investors can buy/sell units of the Scheme in round lot of 1 unit and in multiples thereof. Directly with the Mutual Fund: Investors can buy or sell units of the scheme in creation unit size and its multiples. Further, any application by investors, other than Market Makers, must be for an amount exceeding INR 25 crores. However, the aforementioned threshold of INR 25 crores shall not apply to investors falling under the following categories (until such time as may be specified by SEBI/AMFI): a. Schemes managed by Employee Provident Fund Organisation, India; b. Recognised Provident Funds, approved Gratuity funds and approved superannuation funds under Income Tax Act, 1961. All direct transactions in units of the Scheme by eligible investors with the AMC/the Fund shall be at intra-day NAV based on the actual execution price of the underlying portfolio..
Scheme details(5 Nov 2025)
What it is
- Category
- Other Schemes – ETFs
- Offer
- 6 May 2021 to 14 May 2021
- Started
- 18 May 2021
- Face value
- ₹10
- Listed
- Listed on NSE and BSE
How it is run
- Swing pricing
- No
- Side-pocketing
- Provisions for Segregated Portfolio have been added as as enabler
- Custodian
- Citibank N.A.,HDFC Bank Limited, HSBC and SBI-SG Global Securities Services Private Limited
- Auditor
- M/s BSR & Co. LLP
- Registrar
- Computer Age Management Services Limited
- SEBI code
- ICIC/O/O/EET/21/04/0123